IMbrave 150: Patient Characteristics

The panel analyzes how patient characteristics from the IMbrave 150 trial compare to those in other hepatocellular carcinoma studies.

EP: 1.IMbrave 150: Overview

Now Viewing

EP: 2.IMbrave 150: Patient Characteristics

EP: 3.IMbrave 150: Updated Outcomes

EP: 4.Using Atezolizumab + Bevacizumab in Practice

EP: 5.Vp4 and Baseline Varices Data in IMbrave 150: Clinical Implications

EP: 6.AE Management with Atezolizumab + Bevacizumab

EP: 7.CheckMate 9DW: Overview

EP: 8.Advanced HCC: Key Takeaways

Video content above is prompted by the following:

• How do the patient characteristics from IMbrave 150 compare to other trials that are being studied in HCC?

Recent Videos